Investing Profile

Jamil Beg

InvestorVC
Partner at SV Health Investors
5amventures.comCambridge, Massachusetts
Photo of Jamil Beg, Partner at SV Health Investors

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
The Wharton School Network
823 CONNECTIONS
University of Pennsylvania Network
517 CONNECTIONS
Wharton School of the University of Pennsylvania Network
83 CONNECTIONS
The Wharton School Network
54 CONNECTIONS
MassChallenge Network
47 CONNECTIONS
cb
$100K - $5.0M
$1.5M
3
£200M
CompanyStageDateRound SizeTotal Raised
AdvanCell
Series DJul 2026$320M
Series CFeb 2025$110M
$430M
Co-investors: Christopher Gagliardi (Sanofi Ventures), Bali Muralidhar (Abingworth)
Kinaset Therapeutics
Series ANov 2020$40M
$140M
Co-investors: Daniela Begolo (INKEF Capital)
Board Member BioBreakPresent
Board Member The BioBreak GroupPresent
Senior Director, Business Development & Brand Leader SAGE TherapeuticsPresent
Mentor MassChallengePresent
Board Observer Aprea TherapeuticsPresent
Board Observer Aprea ABPresent
Board Observer AkouosPresent
Board Observer RallybioPresent
Board of Directors Nido BiosciencesPresent
Guest Lecturer The Wharton SchoolPresent
Guest Lecturer Wharton School of the University of PennsylvaniaPresent
Board of Directors Kinaset TherapeuticsPresent
Founding Investor Kinaset TherapeuticsPresent
Founding Investor Renasant BioPresent
Board of Directors AdvanCellPresent
Partner 5AM VenturesPresent
Chief Executive Officer Nido BiosciencesPresent
Founder Nido BiosciencesPresent
Chief Executive Officer Renasant BioPresent
Partner SV Health InvestorsPresent
The Wharton School Master of Business Administration (M.B.A.) Health Care Management, Entrepreneurial Management
University of Pennsylvania BSE Bioengineering
Sign in with Google →
Sign in with Google →